<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations of Sjögren's disease: Exocrine gland disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations of Sjögren's disease: Exocrine gland disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations of Sjögren's disease: Exocrine gland disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan N Baer, MD, MACR</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert I Fox, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sjögren’s disease (SjD) is a chronic systemic autoimmune disorder characterized by lacrimal and salivary gland inflammation with resultant dysfunction. SjD may occur alone (primary form) or in association with a second well-defined rheumatic disease (secondary form). The most common associated diseases are rheumatoid arthritis and systemic lupus erythematosus.</p><p>In primary and secondary SjD, exocrine gland inflammation leads to dry eye and dry mouth [<a href="#rid1">1,2</a>]. These features, when confirmed by objective measures, are often referred to as keratoconjunctivitis sicca and salivary hypofunction, respectively. Marked glandular swelling may occur, and additional related ocular or oral features may be present, as may a wide variety of other disease manifestations [<a href="#rid3">3</a>]. The clinical manifestations of SjD may be divided into the exocrine gland features and the extraglandular disease features, which can potentially affect numerous other organs [<a href="#rid4">4</a>].</p><p>The clinical manifestations of exocrine gland disease in SjD will be reviewed here. The extraglandular manifestations and diagnosis and treatment of both sicca and extraglandular manifestations are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease"</a> and  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease"</a> and  <a class="medical medical_review" href="/z/d/html/14922.html" rel="external">"Treatment of dry eye in Sjögren’s disease: General principles and initial therapy"</a> and  <a class="medical medical_review" href="/z/d/html/14923.html" rel="external">"Treatment of dry mouth and other non-ocular sicca symptoms in Sjögren’s disease"</a> and  <a class="medical medical_review" href="/z/d/html/112281.html" rel="external">"Treatment of moderate to severe dry eye in Sjögren’s disease"</a> and  <a class="medical medical_review" href="/z/d/html/14921.html" rel="external">"Overview of the management and prognosis of Sjögren's disease"</a>.)</p><p class="headingAnchor" id="H2744969261"><span class="h1">PATHOGENESIS AND HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>The dry eye and dry mouth of Sjögren’s disease (SjD) are caused by immune-mediated inflammation directed against the exocrine glands of the eyes and mouth. The pathogenesis of SjD is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5620.html" rel="external">"Pathogenesis of Sjögren’s disease"</a>.)</p><p>Briefly, the histopathologic features of the exocrine disease include extensive lymphocytic infiltration, accompanied by glandular and ductal atrophy  (<a class="graphic graphic_diagnosticimage graphicRef112230" href="/z/d/graphic/112230.html" rel="external">image 1</a>). Lymphocytic infiltrates are primarily located around the striated ducts, leading to periductal foci [<a href="#rid5">5</a>]. In some patients, these lymphocytic infiltrates are organized as ectopic lymphoid structures resembling secondary lymphoid organs, with segregation of T and B cells, presence of CD21+ follicular dendritic cell networks, and high endothelial venules [<a href="#rid6">6</a>]. Germinal centers are a defining histologic feature of these ectopic lymphoid structures and can be identified in approximately 4 percent of minor and 16 percent of parotid gland foci when assessed with immunohistochemical staining for B cell lymphoma 6 protein (Bcl6) [<a href="#rid6">6-8</a>].</p><p>Two other histopathologic features of the salivary gland are characteristic of SjD. The first is the lymphoepithelial lesions, defined by the presence of B cells infiltrating the ductal epithelium and associated ductal epithelial hyperplasia [<a href="#rid9">9-11</a>]. These lymphoepithelial lesions are present in up to 93 percent of parotid gland biopsies compared with 20 to 33 percent of minor salivary gland biopsies [<a href="#rid12">12</a>]. The second feature is an increase in immunoglobulin (Ig) G+ and IgM+ plasma cells and a concomitant decrease in IgA+ plasma cells, relative to control biopsies. The finding of &lt;70 percent IgA+ plasma cells has a specificity of 95 percent and sensitivity of 100 percent for SjD in one study [<a href="#rid13">13</a>].</p><p>The histopathologic process in the major salivary glands is known as benign lymphoepithelial sialadenitis. In the minor salivary glands, it is known as focal lymphocytic sialadenitis and is defined by the presence of multiple aggregates of periductal lymphocytes in areas of gland not affected by interstitial fibrosis, ductal dilatation, and acinar atrophy. The presence of one or more such periductal lymphocytic aggregates, each containing 50 or more cells, per 4 mm<sup>2</sup> of salivary gland tissue is one criterion for the classification of SjD [<a href="#rid7">7,14</a>].</p><p class="headingAnchor" id="H4087078448"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Dry eye and dry mouth are each present in over 85 percent of patients with primary Sjögren’s disease (SjD) [<a href="#rid15">15,16</a>]; the exception is children, in whom recurrent parotitis is typically a more dominant symptom than sicca [<a href="#rid17">17,18</a>]. In addition, presentation with sicca symptoms may vary on the basis of ethnicity, being less common among Asian populations (defined as including persons having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent) [<a href="#rid15">15</a>]. In the vast majority of patients, dry eye and dry mouth symptoms are present in tandem at presentation [<a href="#rid19">19</a>].</p><p>Discrete extraglandular involvement is present in approximately a quarter of SjD patients [<a href="#rid20">20</a>]. However, limb pain and fatigue are common symptoms and are sometimes attributed to systemic involvement. In patients with SjD associated with another rheumatic disease, extraglandular involvement may differ when compared with those with SjD alone [<a href="#rid21">21,22</a>], most likely due to the nonspecificity of the systemic features. For instance, a higher prevalence of interstitial lung disease was observed in patients with an overlap of SjD with rheumatoid arthritis when compared with SjD alone [<a href="#rid23">23</a>]. A higher prevalence of Raynaud phenomenon, arthritis, and central nervous system involvement was observed in a study of 26 patients with an overlap of SjD with systemic lupus erythematosus, when compared with 86 patients with SjD alone [<a href="#rid24">24</a>].</p><p>Extraglandular rather than sicca manifestations may be the presenting feature in approximately 5 to 20 percent of patients [<a href="#rid25">25,26</a>]. This has been reported particularly among patients with peripheral neuropathies and interstitial lung disease, in whom an evaluation may provide evidence for SjD, even in the absence of sicca symptoms [<a href="#rid27">27-29</a>].</p><p>In a multicenter Spanish registry of 1580 patients with primary SjD followed for a mean of 10.2 years, the following frequencies of clinical manifestations were observed [<a href="#rid25">25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms of dry eye and dry mouth were present in 96 to 97 percent of patients at baseline</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal ocular tests and parotid sialography were present in 86 to 88 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Serious systemic disease involvement occurred in 13 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma developed in 4.9 percent</p><p></p><p class="headingAnchor" id="H3"><span class="h1">DRY EYE</span><span class="headingEndMark"> — </span>Common ocular symptoms of dry eyes in patients with Sjögren’s disease (SjD) include irritation, grittiness, itching, a foreign body sensation, and blurry/changeable vision [<a href="#rid3">3</a>]. Findings include diminished tear flow, vital dye staining of devitalized conjunctival cells and punctate areas of exposed corneal epithelial stroma, and increased tear osmolarity. Dry eye in SjD is largely caused by a reduction in the aqueous component of tears  (<a class="graphic graphic_table graphicRef77821" href="/z/d/graphic/77821.html" rel="external">table 1</a>).</p><p>Meibomian gland dysfunction is also common in patients with SjD, with a resultant increase in tear evaporation, compounding the diminished tear production [<a href="#rid30">30,31</a>]. Meibomian gland dysfunction in patients with SjD and its management are described separately. (See  <a class="medical medical_review" href="/z/d/html/14922.html" rel="external">"Treatment of dry eye in Sjögren’s disease: General principles and initial therapy", section on 'Potential harms'</a> and  <a class="medical medical_review" href="/z/d/html/112281.html" rel="external">"Treatment of moderate to severe dry eye in Sjögren’s disease", section on 'Definition and general approach'</a>.)</p><p>Vision-threatening complications from dry eye include corneal melting, ulceration, and perforation, but are fortunately uncommon.</p><p>Major features of dry eye in SjD include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms</strong> – Dry eye usually presents insidiously over a period of several years. The symptoms vary and are often worse in the evening. Affected patients may complain of a "gritty" or "sandy" feeling in their eyes rather than "dryness."</p><p></p><p class="bulletIndent1">Other symptoms include irritation, itching, photophobia, glare, blurred vision, and the accumulation of thick, rope-like strands (mucus filaments) at the inner canthus. Mucus filaments are particularly present upon awakening.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Findings</strong> – Ophthalmologic examination may reveal one or more of the following findings (see  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease", section on 'Tests for dry eye'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Surface epithelial damage, as detected by lissamine green  (<a class="graphic graphic_figure graphicRef97075" href="/z/d/graphic/97075.html" rel="external">figure 1</a>) or Rose Bengal  (<a class="graphic graphic_picture graphicRef59477" href="/z/d/graphic/59477.html" rel="external">picture 1</a>) staining of the interpalpebral bulbar conjunctiva, especially on both the nasal and temporal sides</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Punctate epithelial erosions of the cornea, most often in the inferior aspect, as detected by <a class="drug drug_general" data-topicid="8461" href="/z/d/drug information/8461.html" rel="external">fluorescein</a> staining</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evidence of reduced tear production, as detected by a Schirmer test</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mucus filaments</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dilation of the bulbar conjunctival vessels</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dullness of the conjunctiva and cornea</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rapid tear break-up time</p><p></p><p>Complications of dry eye include corneal ulceration and perforations, which rarely may cause corneal melt [<a href="#rid32">32,33</a>].</p><p>Additional ocular disorders unrelated to dry eye may occur [<a href="#rid3">3</a>]. These conditions, which are seen infrequently in patients with SjD, include anterior and posterior uveitis [<a href="#rid34">34</a>], scleritis [<a href="#rid33">33,35</a>], and optic neuritis [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/5581.html" rel="external">"Uveitis: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5599.html" rel="external">"Clinical manifestations and diagnosis of scleritis"</a> and  <a class="medical medical_review" href="/z/d/html/5251.html" rel="external">"Optic neuritis: Pathophysiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/120953.html" rel="external">"Neurologic manifestations of Sjögren's disease", section on 'Central nervous system disorders'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">DRY MOUTH</span></p><p class="headingAnchor" id="H749855219"><span class="h2">Clinical features of dry mouth</span><span class="headingEndMark"> — </span>Chronic salivary hypofunction in Sjögren’s disease (SjD) has a number of characteristic symptoms and oral findings. Patients with SjD may complain directly of oral dryness (termed "xerostomia") or of complications such as dysphagia and adherence of food to buccal surfaces, describing difficulty eating and swallowing dry food, such as crackers, without drinking liquids. They may also report problems with dentures, changes in taste, and difficulty speaking continuously for long periods.</p><p>Signs of salivary hypofunction include lingual papillary atrophy and lobulation, dry lips, glassy appearance of the palatal oral mucosa, and absent sublingual salivary pooling  (<a class="graphic graphic_picture graphicRef51074" href="/z/d/graphic/51074.html" rel="external">picture 2</a>) [<a href="#rid37">37</a>]. Salivary hypofunction is associated with an increased rate of dental caries  (<a class="graphic graphic_picture graphicRef53927" href="/z/d/graphic/53927.html" rel="external">picture 3</a>) and often with a decrease in the sense of taste and a change in oral microbial flora, including an increase in oral candidiasis [<a href="#rid38">38-40</a>]. (See <a class="local">'Complications of salivary hypofunction'</a> below.)</p><p>Diagnostic testing for the evaluation of salivary hypofunction and the use of labial salivary gland biopsy for identification of histopathologic changes characteristic of SjD are described in detail separately, as are the management of dry mouth in SjD and strategies for the prevention of related complications. (See  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease", section on 'Diagnostic tests'</a> and  <a class="medical medical_review" href="/z/d/html/14923.html" rel="external">"Treatment of dry mouth and other non-ocular sicca symptoms in Sjögren’s disease"</a>.)</p><p>Dry mouth is a common symptom in the population, particularly in older adults [<a href="#rid41">41</a>], but objective evidence of reduced salivary flow is less frequent in healthy older individuals than in patients with SjD [<a href="#rid42">42</a>]. Other causes of dry mouth include a number of drugs and other conditions and systemic disorders  (<a class="graphic graphic_table graphicRef77821" href="/z/d/graphic/77821.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H2349901191"><span class="h2">Complications of salivary hypofunction</span><span class="headingEndMark"> — </span>Salivary hypofunction may result in a number of complications:</p><p class="bulletIndent1"><span class="glyph">●</span>Dental caries, which occur in up to 65 percent of patients, and primarily affect the cervical root and incisal surfaces of the teeth [<a href="#rid43">43,44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oral candidiasis, which may occur in over one-third of patients [<a href="#rid45">45-47</a>]. (See <a class="local">'Oral candidiasis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other types of oral infections, such as bacterial infections of the major salivary glands  (<a class="graphic graphic_picture graphicRef52846" href="/z/d/graphic/52846.html" rel="external">picture 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laryngotracheal reflux, which may lead to frequent throat clearing, cough, substernal pain, and nocturnal awakening that simulates panic attacks [<a href="#rid48">48,49</a>]. Laryngotracheal reflux in SjD is the result of decreased salivary flow, the absence of the normal gastric acid buffer, and reflux of gastric acid into the esophagus and trachea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic esophagitis, also due to impaired clearance of acid and lack of the buffering effects of saliva. (See  <a class="medical medical_review" href="/z/d/html/2257.html" rel="external">"Pathophysiology of reflux esophagitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Weight loss, due to difficulty with chewing and deglutition.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nocturia, which results from attempts on the part of the patients to counter dry mouth by drinking copious volumes of fluids.</p><p></p><p class="headingAnchor" id="H2801192"><span class="h2">Oral candidiasis</span><span class="headingEndMark"> — </span>Oral candidiasis is a common complication of SjD; it may occur in over one-third of patients [<a href="#rid45">45-47</a>]. Symptoms include a painful mouth, sometimes with a burning sensation, and sensitivity to spicy or acidic foods [<a href="#rid50">50</a>]. Findings in SjD patients with oral candidiasis are typically those of erythematous or chronic atrophic candidiasis, including diffuse or patchy erythema, typically affecting the hard palate [<a href="#rid51">51</a>].</p><p>The presentation of oral candidiasis in SjD is in contrast with the typically fluffy white exudates that predominate in patients with human immunodeficiency virus or with immunosuppression due to chemotherapy. The tongue, buccal mucosa, palate, lips, and corners of the lips may be affected, and there may be loss of tongue papillae. Angular cheilitis and atrophic changes of the buccal mucosa are common manifestations in SjD [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">"Oropharyngeal candidiasis in adults", section on 'Clinical manifestations'</a>.)</p><p>Oral candidiasis is often facilitated by the wearing of dentures ("denture stomatitis"), which may need to be removed to determine whether candidiasis is present and to assess the response to treatment [<a href="#rid51">51</a>]. Oral candidiasis is particularly frequent following antibiotic treatment or the use of glucocorticoids.</p><p class="headingAnchor" id="H5"><span class="h1">SALIVARY AND LACRIMAL GLAND ENLARGEMENT</span></p><p class="headingAnchor" id="H3441158098"><span class="h2">Benign glandular enlargement</span><span class="headingEndMark"> — </span>Salivary gland enlargement occurs in up to 50 percent of patients with Sjögren’s disease (SjD) at some point over the course of the disease [<a href="#rid52">52</a>] and is present in 20 to 30 percent of patients in cross-sectional studies [<a href="#rid53">53-55</a>]. It may either be unilateral or bilateral. The glands are usually firm, diffusely enlarged, and nontender. These changes are most obvious in the parotid glands, but the submandibular and other glands may be affected to the same degree  (<a class="graphic graphic_diagnosticimage graphicRef69831" href="/z/d/graphic/69831.html" rel="external">image 2</a> and <a class="graphic graphic_diagnosticimage graphicRef112230" href="/z/d/graphic/112230.html" rel="external">image 1</a>). Salivary gland enlargement may be either chronic or episodic, with swelling followed by reduction over a few weeks.</p><p>Recurrent, paroxysmal swelling of the submandibular and/or parotid glands is a characteristic feature of eosinophilic sialodochitis, a disease sometimes misdiagnosed as SjD. The salivary gland swelling is often associated with itching over the gland and the formation of eosinophil-rich mucus plugs. Up to two-thirds of patients have associated atopy and peripheral blood eosinophilia [<a href="#rid56">56,57</a>].</p><p>Ultrasonography is the preferred imaging tool to determine whether there is salivary gland involvement, since it is non-irradiating and can be performed at the "bedside" in real-time by the clinician (see  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease", section on 'Salivary gland ultrasonography'</a>). Hypoechoic foci are the most characteristic ultrasonographic abnormality  (<a class="graphic graphic_diagnosticimage graphicRef129450" href="/z/d/graphic/129450.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef129887" href="/z/d/graphic/129887.html" rel="external">image 4</a>) [<a href="#rid17">17,58,59</a>]. In a meta-analysis of 14 studies, the pooled sensitivity of salivary gland ultrasonography to detect characteristic glandular abnormalities was 75 to 84 percent and pooled specificity was 88 to 95 percent, depending on the scoring system [<a href="#rid60">60</a>].</p><p>Sialograms obtained after instilling contrast into the salivary ducts may reveal sialectasis and pruning of the peripheral branches  (<a class="graphic graphic_picture graphicRef54109" href="/z/d/graphic/54109.html" rel="external">picture 5</a>). However, sialography is less commonly used today. Magnetic resonance imaging (MRI) may show diffuse enlargement of the glands with or without sialectasis  (<a class="graphic graphic_diagnosticimage graphicRef112230" href="/z/d/graphic/112230.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef112229" href="/z/d/graphic/112229.html" rel="external">image 5</a>).</p><p>Lacrimal gland enlargement is a rare presenting feature of SjD [<a href="#rid61">61</a>], being more commonly seen in IgG4-related disease, sarcoidosis, and lymphoma; its development in a patient with known SjD should raise concern for the latter, particularly if there is asymmetric involvement.</p><p>Patients with SjD are at increased risk for lymphoma, which is described briefly here (see <a class="local">'Lymphoma'</a> below) and in detail separately (see  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Lymphoma'</a>). A number of other conditions may also cause unilateral or bilateral glandular enlargement, including infectious, obstructive, systemic, and other disorders  (<a class="graphic graphic_table graphicRef77821" href="/z/d/graphic/77821.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3360529095"><span class="h2">Lymphoma</span><span class="headingEndMark"> — </span>Lymphoma is one of the most serious complications of SjD; it is estimated to occur in up to 5 to 10 percent of patients, consistent with a five- to ninefold increase in risk compared with an age-matched healthy population [<a href="#rid62">62</a>]. These tumors can arise in exocrine glands, lymph nodes, and from mucosa-associated lymphoid tissues. Lymphoma in SjD is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Lymphoma'</a>.)</p><p>Briefly, findings associated with lymphoma may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent unilateral or bilateral glandular swelling, especially when previous swelling has been transient or intermittent</p><p class="bulletIndent1"><span class="glyph">●</span>Hard, nodular texture to the gland</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of cryoglobulinemia, with cutaneous vasculitis or palpable purpura</p><p class="bulletIndent1"><span class="glyph">●</span>Hypocomplementemia</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic features (malaise, weight loss, fever)</p><p></p><p class="headingAnchor" id="H3595572088"><span class="h1">OTHER FEATURES</span><span class="headingEndMark"> — </span>Other organs that may be affected by symptoms and sequelae of dryness, as well as other clinical manifestations, are described in detail separately. The dryness in these areas is explained only in part by exocrine deficiencies. Briefly, these include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cutaneous manifestations</strong> – Excessively dry skin, xerosis, is the most common cutaneous manifestation of Sjögren’s disease (SjD) and often associated with pruritus. However, demonstration of an inflammatory process involving eccrine glands has been inconsistent [<a href="#rid63">63</a>]. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Skin'</a> and  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Xerosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory tract manifestations</strong> – Upper and lower airway involvement may be associated with persistent dry cough, hoarseness, and nasal dryness and crusting. Inflammation of submucosal glands in the respiratory tract was originally demonstrated by Sjögren in his initial description of the syndrome [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Lungs'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gynecologic manifestations</strong> – Vulvovaginal dryness, pruritus, and dyspareunia may occur, and urogenital involvement may be complicated by bacterial and candidal infections. However, the vagina has no secretory glands, and its basal humidification and lubrication during sexual arousal depends upon fluid transudation across the vaginal epithelium. Increased lymphocytic infiltration is found in vagina biopsies of women with SjD compared with controls, and this might lead to vascular dysfunction [<a href="#rid65">65</a>]. Involvement in SjD of the Bartholin and Skene glands at the vaginal vestibule, which have a minor role in lubrication of the vulva, has been suggested but never proven [<a href="#rid52">52</a>]. Gynecologic involvement in SjD is described separately. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Urogenital disease'</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/580.html" rel="external">"Patient education: Sjögren's disease (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12141883"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Sjögren’s disease (SjD) is a chronic systemic autoimmune disorder characterized by diminished lacrimal and salivary gland function. SjD occurs in primary and secondary forms. The major signs of exocrine gland involvement are dry eyes and dry mouth, caused by immune-mediated inflammation directed against the exocrine glands of the eyes and mouth. Histopathologic features include extensive focal lymphocytic infiltration, with glandular and ductal atrophy. (See <a class="local">'Pathogenesis and histopathology'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dry eye, caused by a reduction in the aqueous component of tears, usually presents insidiously over a period of several years. Patients may complain of a "gritty" or "sandy" feeling in their eyes, especially at night, rather than "dryness." Physical examination may include punctate conjunctival and corneal damage and evidence of reduced tear production. (See <a class="local">'Dry eye'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dry mouth symptoms result from chronic salivary hypofunction. Patients may also complain of dysphagia, adherence of food to buccal surfaces, problems with dentures, changes in taste, or an inability to eat dry food or to speak continuously for long periods. Chronic complications include dental caries and oral candidiasis. (See <a class="local">'Clinical features of dry mouth'</a> above and <a class="local">'Complications of salivary hypofunction'</a> above and <a class="local">'Oral candidiasis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Salivary gland enlargement may be either chronic or episodic, and glands are usually firm, diffuse, and nontender. It most often affects the parotid glands, but the submandibular glands may be similarly involved. A particularly hard or nodular gland may suggest a neoplasm. Lacrimal gland enlargement can also occur in SjD. (See <a class="local">'Salivary and lacrimal gland enlargement'</a> above.)</p><p></p><p class="headingAnchor" id="H1651249356"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Paul Creamer, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mariette X, Criswell LA. Primary Sjögren's Syndrome. N Engl J Med 2018; 378:931.</a></li><li><a class="nounderline abstract_t">Wang X, Bootsma H, Terpstra J, et al. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome. Rheumatology (Oxford) 2020; 59:3003.</a></li><li><a class="nounderline abstract_t">Vivino FB, Bunya VY, Massaro-Giordano G, et al. Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol 2019; 203:81.</a></li><li><a class="nounderline abstract_t">Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study. J Intern Med 1996; 239:475.</a></li><li><a class="nounderline abstract_t">Kroese FGM, Haacke EA, Bombardieri M. The role of salivary gland histopathology in primary Sjögren's syndrome: promises and pitfalls. Clin Exp Rheumatol 2018; 36 Suppl 112:222.</a></li><li><a class="nounderline abstract_t">Nakshbandi U, Haacke EA, Bootsma H, et al. Bcl6 for identification of germinal centres in salivary gland biopsies in primary Sjögren's syndrome. Oral Dis 2020; 26:707.</a></li><li><a class="nounderline abstract_t">Daniels TE, Cox D, Shiboski CH, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011; 63:2021.</a></li><li><a class="nounderline abstract_t">Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003; 48:3187.</a></li><li><a class="nounderline abstract_t">Pijpe J, Kalk WW, van der Wal JE, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2007; 46:335.</a></li><li><a class="nounderline abstract_t">Ihrler S, Zietz C, Sendelhofert A, et al. Lymphoepithelial duct lesions in Sjögren-type sialadenitis. Virchows Arch 1999; 434:315.</a></li><li><a class="nounderline abstract_t">van Ginkel MS, Haacke EA, Bootsma H, et al. Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patients. Clin Exp Rheumatol 2019; 37 Suppl 118:42.</a></li><li><a class="nounderline abstract_t">Haacke EA, Bootsma H, Spijkervet FKL, et al. FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients. J Autoimmun 2017; 81:90.</a></li><li><a class="nounderline abstract_t">de Wilde PC, Vooys GP, Baak JP, et al. Quantitative immunohistologic and histomorphometric diagnostic criteria for Sjögren's syndrome. Pathol Res Pract 1989; 185:778.</a></li><li><a class="nounderline abstract_t">Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017; 76:9.</a></li><li><a class="nounderline abstract_t">Brito-Zerón P, Acar-Denizli N, Zeher M, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis 2017; 76:1042.</a></li><li><a class="nounderline abstract_t">Shiboski CH, Baer AN, Shiboski SC, et al. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry. Arthritis Care Res (Hoboken) 2018; 70:284.</a></li><li><a class="nounderline abstract_t">Hammenfors DS, Valim V, Bica BERG, et al. Juvenile Sjögren's Syndrome: Clinical Characteristics With Focus on Salivary Gland Ultrasonography. Arthritis Care Res (Hoboken) 2020; 72:78.</a></li><li><a class="nounderline abstract_t">Yokogawa N, Lieberman SM, Sherry DD, Vivino FB. Features of childhood Sjögren's syndrome in comparison to adult Sjögren's syndrome: considerations in establishing child-specific diagnostic criteria. Clin Exp Rheumatol 2016; 34:343.</a></li><li><a class="nounderline abstract_t">Brito-Zerón P, Theander E, Baldini C, et al. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 2016; 12:137.</a></li><li><a class="nounderline abstract_t">Retamozo S, Acar-Denizli N, Rasmussen A, et al. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol 2019; 37 Suppl 118:97.</a></li><li><a class="nounderline abstract_t">Kollert F, Fisher BA. Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'? Rheumatology (Oxford) 2020; 59:1218.</a></li><li><a class="nounderline abstract_t">Mavragani CP, Moutsopoulos HM. Primary versus Secondary Sjögren Syndrome: Is It Time To Reconsider These Terms? J Rheumatol 2019; 46:665.</a></li><li><a class="nounderline abstract_t">He J, Ding Y, Feng M, et al. Characteristics of Sjögren's syndrome in rheumatoid arthritis. Rheumatology (Oxford) 2013; 52:1084.</a></li><li><a class="nounderline abstract_t">Manoussakis MN, Georgopoulou C, Zintzaras E, et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004; 50:882.</a></li><li><a class="nounderline abstract_t">Flores-Chávez A, Kostov B, Solans R, et al. Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry). Clin Exp Rheumatol 2018; 36 Suppl 112:121.</a></li><li class="breakAll">Vivino FB. Diagnosis and evaluation of Sjögren's syndrome. In: Sjögren's Syndrome: A Clinical Handbook, Vivino FB (Ed), Elsevier, Amsterdam 2020. p.21.</li><li><a class="nounderline abstract_t">Manfredi A, Sebastiani M, Cerri S, et al. Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement. Clin Rheumatol 2017; 36:1261.</a></li><li><a class="nounderline abstract_t">Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005; 128:2518.</a></li><li><a class="nounderline abstract_t">Sène D, Cacoub P, Authier FJ, et al. Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases. Medicine (Baltimore) 2013; 92:e10.</a></li><li><a class="nounderline abstract_t">Shimazaki J, Goto E, Ono M, et al. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 1998; 105:1485.</a></li><li><a class="nounderline abstract_t">Sullivan DA, Dana R, Sullivan RM, et al. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome. Ophthalmic Res 2018; 59:193.</a></li><li><a class="nounderline abstract_t">Vivino FB, Minerva P, Huang CH, Orlin SE. Corneal melt as the initial presentation of primary Sjögren's syndrome. J Rheumatol 2001; 28:379.</a></li><li><a class="nounderline abstract_t">Akpek EK, Mathews P, Hahn S, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome. Ophthalmology 2015; 122:56.</a></li><li><a class="nounderline abstract_t">Rosenbaum JT, Bennett RM. Chronic anterior and posterior uveitis and primary Sjögren's syndrome. Am J Ophthalmol 1987; 104:346.</a></li><li><a class="nounderline abstract_t">Braithwaite T, Adderley NJ, Subramanian A, et al. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease. Arthritis Rheumatol 2021; 73:1267.</a></li><li><a class="nounderline abstract_t">Sun JY, Liu Z, Zhao P, Liu T. Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review. Medicine (Baltimore) 2016; 95:e5194.</a></li><li class="breakAll">https://www.dentalhealth.org/uploads/download/resourcefiles/download_68_1_The%20Challacombe%20Scale.pdf (Accessed on March 07, 2017).</li><li><a class="nounderline abstract_t">Schiødt M, Christensen LB, Petersen PE, Thorn JJ. Periodontal disease in primary Sjögren's syndrome. Oral Dis 2001; 7:106.</a></li><li><a class="nounderline abstract_t">Wu AJ. The oral component of Sjögren's syndrome: pass the scalpel and check the water. Curr Rheumatol Rep 2003; 5:304.</a></li><li><a class="nounderline abstract_t">Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, et al. Oral candidiasis and Sjögren's syndrome. J Rheumatol 1998; 25:911.</a></li><li><a class="nounderline abstract_t">Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999; 159:1359.</a></li><li><a class="nounderline abstract_t">Hochberg MC, Tielsch J, Munoz B, et al. Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation. J Rheumatol 1998; 25:486.</a></li><li><a class="nounderline abstract_t">Daniels TE, Silverman S Jr, Michalski JP, et al. The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1975; 39:875.</a></li><li><a class="nounderline abstract_t">Berman N, Vivino F, Baker J, et al. Risk factors for caries development in primary Sjogren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 2019; 128:117.</a></li><li><a class="nounderline abstract_t">van der Reijden WA, Vissink A, Veerman EC, Amerongen AV. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome. Ann Rheum Dis 1999; 58:465.</a></li><li><a class="nounderline abstract_t">Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J Otolaryngol 1997; 26:300.</a></li><li><a class="nounderline abstract_t">Tapper-Jones L, Aldred M, Walker DM. Prevalence and intraoral distribution of Candida albicans in Sjögren's syndrome. J Clin Pathol 1980; 33:282.</a></li><li><a class="nounderline abstract_t">Belafsky PC, Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep 2003; 5:297.</a></li><li><a class="nounderline abstract_t">Postma GN, Belafsky PC, Aviv JE, Koufman JA. Laryngopharyngeal reflux testing. Ear Nose Throat J 2002; 81:14.</a></li><li><a class="nounderline abstract_t">Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, et al. Oral manifestations in patients with Sjögren's syndrome. J Rheumatol 1998; 25:906.</a></li><li><a class="nounderline abstract_t">Hernandez YL, Daniels TE. Oral candidiasis in Sjögren's syndrome: prevalence, clinical correlations, and treatment. Oral Surg Oral Med Oral Pathol 1989; 68:324.</a></li><li><a class="nounderline abstract_t">Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965; 44:187.</a></li><li><a class="nounderline abstract_t">Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27:147.</a></li><li><a class="nounderline abstract_t">Retamozo S, Acar-Denizli N, Horváth IF, et al. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. Clin Exp Rheumatol 2021; 39 Suppl 133:166.</a></li><li><a class="nounderline abstract_t">Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64:475.</a></li><li><a class="nounderline abstract_t">Baer AN, Okuhama A, Eisele DW, et al. Eosinophilic sialodochitis: redefinition of 'allergic parotitis' and 'sialodochitis fibrinosa'. Oral Dis 2017; 23:840.</a></li><li><a class="nounderline abstract_t">Carey B, O'Neill N, Brown J, et al. Eosinophilic sialodochitis: An emerging atopic condition. Oral Dis 2022; 28:648.</a></li><li><a class="nounderline abstract_t">Jousse-Joulin S, Nowak E, Cornec D, et al. Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability. RMD Open 2017; 3:e000364.</a></li><li><a class="nounderline abstract_t">Jousse-Joulin S, Gatineau F, Baldini C, et al. Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndrome. J Intern Med 2020; 287:180.</a></li><li><a class="nounderline abstract_t">Zhou M, Song S, Wu S, et al. Diagnostic accuracy of salivary gland ultrasonography with different scoring systems in Sjögren's syndrome: a systematic review and meta-analysis. Sci Rep 2018; 8:17128.</a></li><li><a class="nounderline abstract_t">Parkin B, Chew JB, White VA, et al. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome? Ophthalmology 2005; 112:2040.</a></li><li><a class="nounderline abstract_t">Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 2015; 168:317.</a></li><li><a class="nounderline abstract_t">Mitchell J, Greenspan J, Daniels T, et al. Anhidrosis (hypohidrosis) in Sjögren's syndrome. J Am Acad Dermatol 1987; 16:233.</a></li><li><a class="nounderline abstract_t">Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tränendrüsen). Acta Ophthalmol Scand 1933; 11:1.</a></li><li><a class="nounderline abstract_t">van Nimwegen JF, van der Tuuk K, Liefers SC, et al. Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study. Rheumatology (Oxford) 2020; 59:2806.</a></li></ol></div><div id="topicVersionRevision">Topic 5607 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29514034" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Primary Sjögren's Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32159757" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31022578" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8656140" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30156550" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The role of salivary gland histopathology in primary Sjögren's syndrome: promises and pitfalls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31912593" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bcl6 for identification of germinal centres in salivary gland biopsies in primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21480190" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14613282" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16891656" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10335942" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Lymphoepithelial duct lesions in Sjögren-type sialadenitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31074726" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28390747" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2696953" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Quantitative immunohistologic and histomorphometric diagnostic criteria for Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27789466" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27899373" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28437595" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30697959" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Juvenile Sjögren's Syndrome: Clinical Characteristics With Focus on Salivary Gland Ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26812559" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Features of childhood Sjögren's syndrome in comparison to adult Sjögren's syndrome: considerations in establishing child-specific diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26691952" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31464664" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32025734" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31262751" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Primary versus Secondary Sjögren Syndrome: Is It Time To Reconsider These Terms?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23382356" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Characteristics of Sjögren's syndrome in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15022331" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30156546" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30156546" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28324200" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16049042" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982054" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9709762" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Meibomian gland dysfunction in patients with Sjögren syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29627826" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11246683" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Corneal melt as the initial presentation of primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25178806" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3661643" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Chronic anterior and posterior uveitis and primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33728815" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27858858" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27858858" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11355434" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Periodontal disease in primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14531958" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The oral component of Sjögren's syndrome: pass the scalpel and check the water.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9598890" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Oral candidiasis and Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10386512" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Dry eye and dry mouth in the elderly: a population-based assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9517768" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1055974" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The oral component of Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31196703" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Risk factors for caries development in primary Sjogren syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10419864" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9343767" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6991530" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevalence and intraoral distribution of Candida albicans in Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14531957" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The laryngeal and esophageal manifestations of Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12353426" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Laryngopharyngeal reflux testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9598889" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Oral manifestations in patients with Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2788854" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Oral candidiasis in Sjögren's syndrome: prevalence, clinical correlations, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14315274" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6696772" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34919044" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22563590" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27748012" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Eosinophilic sialodochitis: redefinition of 'allergic parotitis' and 'sialodochitis fibrinosa'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33660371" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Eosinophilic sialodochitis: An emerging atopic condition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28879042" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31618794" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30459471" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Diagnostic accuracy of salivary gland ultrasonography with different scoring systems in Sjögren's syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16168486" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25316606" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3819059" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Anhidrosis (hypohidrosis) in Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tränendrüsen)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32044981" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
